ロード中...
Argatroban versus heparin in patients without heparin-induced thrombocytopenia during venovenous extracorporeal membrane oxygenation: a propensity-score matched study
BACKGROUND: During venovenous extracorporeal membrane oxygenation (vvECMO), direct thrombin inhibitors are considered by some potentially advantageous over unfractionated heparin (UFH). We tested the hypothesis that Argatroban is non-inferior to UFH regarding thrombosis and bleeding during vvECMO. M...
保存先:
| 出版年: | Crit Care |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8081564/ https://ncbi.nlm.nih.gov/pubmed/33910609 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13054-021-03581-x |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|